HK1245131A1 - 用於治療炎症性疾病的包含十六酰胺乙醇pea和番茄紅素的組合物 - Google Patents

用於治療炎症性疾病的包含十六酰胺乙醇pea和番茄紅素的組合物

Info

Publication number
HK1245131A1
HK1245131A1 HK18104808.4A HK18104808A HK1245131A1 HK 1245131 A1 HK1245131 A1 HK 1245131A1 HK 18104808 A HK18104808 A HK 18104808A HK 1245131 A1 HK1245131 A1 HK 1245131A1
Authority
HK
Hong Kong
Prior art keywords
palmitoylethanolamide
lycopene
pea
treatment
combination
Prior art date
Application number
HK18104808.4A
Other languages
English (en)
Inventor
Raffaele Migliaccio
Antonella Sardei
Carmela Migliaccio
Original Assignee
Raffaele Migliaccio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raffaele Migliaccio filed Critical Raffaele Migliaccio
Publication of HK1245131A1 publication Critical patent/HK1245131A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK18104808.4A 2015-06-04 2018-04-12 用於治療炎症性疾病的包含十六酰胺乙醇pea和番茄紅素的組合物 HK1245131A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUB20151255 2015-06-04
PCT/IB2016/053191 WO2016193905A1 (en) 2015-06-04 2016-05-31 Combination comprising palmitoylethanolamide (pea) and lycopene for use in the treatment of inflammatory diseases

Publications (1)

Publication Number Publication Date
HK1245131A1 true HK1245131A1 (zh) 2018-08-24

Family

ID=54288890

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18104808.4A HK1245131A1 (zh) 2015-06-04 2018-04-12 用於治療炎症性疾病的包含十六酰胺乙醇pea和番茄紅素的組合物

Country Status (9)

Country Link
US (2) US10350179B2 (zh)
EP (1) EP3302451B1 (zh)
CA (1) CA2986371C (zh)
DK (1) DK3302451T3 (zh)
ES (1) ES2965035T3 (zh)
FI (1) FI3302451T3 (zh)
HK (1) HK1245131A1 (zh)
MA (1) MA47844A (zh)
WO (1) WO2016193905A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700068608A1 (it) * 2017-06-20 2018-12-20 Neilos S R L Composizione per trattamento o prevenzione di una malattia neurodegenerativa
PH12018000227B1 (en) 2017-09-05 2019-03-11 Frimline Private Ltd A pharmaceutical composition for improving or preventing progression of chronic kidney disease
CN115606802A (zh) * 2022-10-21 2023-01-17 中国农业大学 番茄红素在制备修复肠屏障损伤的产品中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1257697B (it) 1992-04-24 1996-02-01 Lifegroup Spa N-acil derivati di aminoalcooli come agenti terapeutici attivi sull'edema neurogenico endoneurale a livello del nervo periferico.
IL184575A0 (en) * 2007-07-12 2008-01-20 Lycored Ltd Synergistic combinations for treating hypertension
TWI432189B (zh) * 2011-12-30 2014-04-01 Univ China Medical 使用油醯基乙醇醯胺來治療癌症
NL2011448C2 (en) 2012-09-17 2015-01-29 Jp Russell Science Holding Ltd Pharmaceutical or neutraceutical composition comprising palmitoylethanolamide particles.

Also Published As

Publication number Publication date
US10350179B2 (en) 2019-07-16
ES2965035T3 (es) 2024-04-10
MA47844A (fr) 2021-05-05
US20180140565A1 (en) 2018-05-24
EP3302451A1 (en) 2018-04-11
CA2986371A1 (en) 2016-12-08
FI3302451T3 (fi) 2023-12-11
CA2986371C (en) 2022-05-03
EP3302451B1 (en) 2023-09-06
DK3302451T3 (da) 2023-12-04
WO2016193905A1 (en) 2016-12-08
US10987323B2 (en) 2021-04-27
US20190282520A1 (en) 2019-09-19

Similar Documents

Publication Publication Date Title
RS59446B1 (sr) Blautia stercosis i wexlerae za upotrebu u lečenju inflamatornih i autoimunskih bolesti
GB201517215D0 (en) Use of cannabinoids in the treatment of inflammatory skin diseases
GB2548873B (en) Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
HRP20211272T8 (hr) 24-hidroksisteroli supstituirani na poziciji 11 za uporabu u liječenju stanja povezanih sa nmda
EP3337465A4 (en) Compositions and methods of use in combination for the treatment and diagnosis of autoimmune diseases
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
IL268210A (en) Use of gaboxadol in the treatment of tinnitus
PL3277280T3 (pl) Izomiosmina do zastosowania w leczeniu chorób autoimmunologicznych
GB201515986D0 (en) Use of cannabinoids in the treatment of mental disorders
ZA201704726B (en) Peptides and their use in the treatment of skin
IL246855A0 (en) Materials for use in the treatment of retinitis
HK1245131A1 (zh) 用於治療炎症性疾病的包含十六酰胺乙醇pea和番茄紅素的組合物
SG11201705524SA (en) Compositions and methods for the treatment of inflammation and pain
ZA201905402B (en) Compounds and their use in the treatment of schistosomiasis
RS63070B1 (sr) Kompozicije i postupci za upotrebu u lečenju homocistinurije
EP3302530A4 (en) Cdh26 based therapeutic agents and their use
PT3548006T (pt) Composição para utilização no tratamento de alterações intestinais
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
IL273863B1 (en) Hemorrhoid treatment device
ZA201802201B (en) Novel formulation and treatment methods
GB201521442D0 (en) Polytpeptides and analogues thereof for use in the treatment of diabetes and bone disorders
IL250244B (en) Prevention and treatment of inflammatory skin diseases